Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06390306
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-04-18
Brief Title:
The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP
Sponsor:
Peking University Peoples Hospital
Organization:
Peking University Peoples Hospital
Organization Data
Organization:
Peking University Peoples Hospital
Class:
OTHER
Study ID:
2023PHB323-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University Peoples Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Qian Jiang
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Peking University Peoples Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Beijing Chuiyangliu Hospital | OTHER_GOV |
| Wuhan Union Hospital China | OTHER |
| Henan Cancer Hospital | OTHER_GOV |
| Zhejiang University | OTHER |
| Peking Union Medical College | OTHER |
| Nanfang Hospital Southern Medical University | OTHER |